Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 18Lymphoid 14Sarcoma 2Plasma cell 2Other neoplasm 1Myeloid 1

Conditions

Sarcoma 85Osteosarcoma 30Neuroectodermal Tumors, Primitive, Peripheral 16Fibrosarcoma 16Rhabdomyosarcoma 14Liposarcoma 14Hemangiosarcoma 13Neurofibrosarcoma 12Leiomyosarcoma 12Histiocytoma, Malignant Fibrous 12Sarcoma, Synovial 11Malignant mesenchymal tumor 9Sarcoma, Ewing 8Ovarian Neoplasms 8Hemangiopericytoma, Malignant 8Kidney Neoplasms 6Dendritic Cell Sarcoma, Interdigitating 6Wilms Tumor 5Sarcoma, Alveolar Soft Part 5Neoplasms 5Desmoplastic Small Round Cell Tumor 5Chondrosarcoma 5Carcinoma, Renal Cell 5Neuroblastoma 4Neoplasm Metastasis 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Dermatofibrosarcoma 4Chondrosarcoma, Extraskeletal Myxoid 4Central Nervous System Neoplasms 4

Interventions

Cyclophosphamide 48fludarabine phosphate 28Filgrastim 27Radiotherapy 26Antilymphocyte Serum 26Busulfan 24Cyclosporine 23Peripheral Blood Stem Cell Transplantation 19Mycophenolic Acid 18Cord Blood Stem Cell Transplantation 17Methylprednisolone 16Methotrexate 16Melphalan 15Etoposide 15Tacrolimus 12Whole-Body Irradiation 11Cytarabine 9Thiotepa 6Vincristine 5Psychiatric Rehabilitation 5sargramostim 4aldesleukin 4Sirolimus 4Leucovorin 4Granulocyte Colony-Stimulating Factor 4fludarabine 3Prednisone 3Early Intervention, Educational 3Daunorubicin 3glucarpidase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia × Ifosfamide × Sarcoma × Clear all
NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

NCT00018954 2012-02-20

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡